We are live on ! Find out more
LAB icon

Standard BioTools
LAB

84 hedge funds and large institutions have $227M invested in Standard BioTools in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 28 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more call options, than puts

Call options by funds: $189K | Put options by funds: $131K

2.34% more ownership

Funds ownership: 95.42% → 97.77% (+2.3%)

5% more capital invested

Capital invested by funds: $217M → $227M (+$10.3M)

0% more funds holding

Funds holding: 84 → 84 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 15

4% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 28

Holders
84
Holders Change
–
Holders Change %
0%
% of All Funds
1.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
27
Reduced
28
Closed
15
Calls
$189K
Puts
$131K
Net Calls
+$58K
Net Calls Change
+$47K

Top Buyers

1
Russell Investments Group
Russell Investments Group
United Kingdom
+$3.9M
2
LCS
Levin Capital Strategies
New York
+$2.81M
3
SSA
Schonfeld Strategic Advisors
New York
+$858K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$711K
5
Renaissance Technologies
Renaissance Technologies
New York
+$674K

Top Sellers

1
BlackRock
BlackRock
New York
-$1.21M
2
Goldman Sachs
Goldman Sachs
New York
-$813K
3
Northern Trust
Northern Trust
Illinois
-$602K
4
Millennium Management
Millennium Management
New York
-$540K
5
Morgan Stanley
Morgan Stanley
New York
-$498K
Name Holding Trade Value Shares
Change 		Change in
Stake
LCS
1
Levin Capital Strategies
New York
$60.8M +$2.81M +492,914 +5%
Primecap Management
2
Primecap Management
California
$34.5M +$28.5K +5,000 +0.1%
Neuberger Berman Group
3
Neuberger Berman Group
New York
$26.9M -$60.3K -10,588 -0.2%
Russell Investments Group
4
Russell Investments Group
United Kingdom
$26.2M +$3.9M +684,781 +18%
BlackRock
5
BlackRock
New York
$11.9M -$1.21M -212,482 -10%
O
6
OrbiMed
New York
$9.44M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$7.68M -$277K -48,623 -4%
Renaissance Technologies
8
Renaissance Technologies
New York
$6.38M +$674K +118,200 +12%
State Street
9
State Street
Massachusetts
$3.54M -$46.8K -8,212 -1%
HVC
10
Healthcare Value Capital
New Jersey
$2.68M +$225K +39,500 +10%
PAM
11
Panagora Asset Management
Massachusetts
$2.6M -$450K -78,961 -15%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$2.58M +$200K +35,091 +9%
Acadian Asset Management
13
Acadian Asset Management
Massachusetts
$2.54M +$711K +124,708 +41%
Northern Trust
14
Northern Trust
Illinois
$2.17M -$602K -105,655 -23%
SSA
15
Schonfeld Strategic Advisors
New York
$1.79M +$858K +150,494 +101%
Millennium Management
16
Millennium Management
New York
$1.77M -$540K -94,681 -24%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$1.6M +$65.3K +11,457 +4%
Jacobs Levy Equity Management
18
Jacobs Levy Equity Management
New Jersey
$1.52M +$55.8K +9,791 +4%
Fuller & Thaler Asset Management
19
Fuller & Thaler Asset Management
California
$1.29M – – –
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$1.15M +$316K +55,376 +40%
AC
21
Alexandria Capital
Virginia
$1.13M – – –
Connor, Clark & Lunn Investment Management (CC&L)
22
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.08M -$38.2K -6,700 -4%
PCM
23
Perkins Capital Management
Minnesota
$1.01M +$86.9K +15,250 +10%
BCM
24
Bridgeway Capital Management
Texas
$1M – – –
Norges Bank
25
Norges Bank
Norway
$979K – – –
1
2 3 4

LAB Hedge Fund Activity: Q2 2018 in Review

84 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q2 2018, worth a combined $227M — up 4.7% from $217M a quarter earlier.

Fund positioning in LAB was balanced in Q2 2018: 15 funds opened new positions, 15 closed out, 27 added to existing stakes and 28 trimmed.

The largest buyer was Russell Investments Group, adding an estimated $3.9M. The largest seller was BlackRock, cutting an estimated $1.21M.

  • 84 institutional investors held Standard BioTools (LAB) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $227M of Standard BioTools stock for Q2 2018, up 4.7% quarter-over-quarter.
  • 15 funds opened new Standard BioTools positions in Q2 2018 and 15 closed out, a net change of 0 holders.
  • The largest Standard BioTools buyer in Q2 2018 was Russell Investments Group, an estimated $3.9M added.
  • The largest Standard BioTools seller in Q2 2018 was BlackRock, an estimated $1.21M sold.

Based on aggregated 13F filings for Q2 2018.